Home LiteratureArticle Details
PMID: 9670778 Published · ppublish English Journal Article Review

Isoprenoid biosynthesis via the mevalonate-independent route, a novel target for antibacterial drugs?

Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques ·Vol. 50 ·1998-00-00 ·Pages 135-54

Rohmer M

Abstract

Mevalonate was accepted as the universal precursor of all isoprenoids. This assertion was however revealed to be partially incorrect. Incorporation of 13C labeled acetate and glucose into bacterial triterpenoids of the hopane series allowed for the discovery and the partial elucidation of a novel biosynthetic pathway leading to isopentenyl diphosphate. The C5 skeleton of isoprenic units results from the condensation of (hydroxyethyl)thiamin on the carbonyl group of glyceraldehyde 3-phosphate, yielding D-1-deoxyxylulose 1-phosphate. A subsequent intramolecular rearrangement is involved in the formation of the branched isoprenic skeleton. 2C-Methyl-D-erythritol (or its mono- or diphosphate) was shown to be a putative intermediate. This pathway is widespread in bacteria including opportunistic pathogens or innocuous species related to well-known pathogens. In plants, it is involved in the formation of essential chloroplast isoprenoids (carotenoids, phytol, plastoquinone) and of probably most other plastid related isoprenoids of more restricted distribution (isoprene, mono- and diterpenoids). Therefore it potentially represents a novel target for antibacterial drugs and herbicides.

MeSH Terms
Anti-Bacterial Agents/pharmacology Bacteria/drug effects,metabolism Hemiterpenes Herbicides/pharmacology Mevalonic Acid/metabolism Organophosphorus Compounds/metabolism
Chemicals
Anti-Bacterial Agents Hemiterpenes Herbicides Organophosphorus Compounds isopentenyl pyrophosphate Mevalonic Acid
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Rohmer M
Université Louis Pasteur CNRS, Institut Le Bel, Strasbourg, France.
Article Info
Journal
Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques
Abbr.
Prog Drug Res
ISSN
0071-786X
Published
1998-00-00
Pages
135-54
Language
English
Region
Switzerland
NLM ID
1304021
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com